Based on the specific types of MSAs, we categorized the patients into four groups: anti-MDA5 antibody, anti-synthetase antibody, other myositis antibodies excluding anti-MDA5 and anti-synthetase, and negative myositis antibodies. This evidence concerns the gene IFIH1 and myositis disease.